Publications: P Samir Agrawal

Agrawal S, Bapat A, Eades CP, Gandhi S ( 2025 ) . Invasive Fungal Disease Associated With Targeted Agents for Acute Myeloid Leukaemia: A Systematic Review . eJHaem vol. 6 , ( 2 ) Article e1105 ,

Ward H, Abdolrasouli A, Offiah C, Agrawal S, Hadjimichael E, Cottom H, Ligaj M, Bapat A ( 2025 ) . Invasive Sino-Orbital Aspergillosis and Tinea Corporis Co-Infection in a Returned Traveler from Flooded Sylhet, Bangladesh . The American Journal of Tropical Medicine and Hygiene vol. 112 , ( 1 ) 150 - 152 .

Schelenz S, Agrawal S, Brady A, Kiely G, Riaz Z, Howes E, Felton T, Micallef C et al. ( 2024 ) . Antifungal stewardship in the UK: where are we now? . JAC-Antimicrobial Resistance vol. 7 , ( 1 ) Article dlae209 ,

Agrawal S, Bapat A, Amos J, Howes E, Ashfield T ( 2024 ) . Adopting prospective antimicrobial stewardship (AMS) practice in high-risk immunosuppressed groups: an urgent call to action in the era of antimicrobial resistance (AMR) . JAC-Antimicrobial Resistance vol. 6 , ( 5 ) Article dlae145 ,

Bapat A, Drumright LN, Caldwell L, Jimenez-England F, Lambourne J, Agrawal S ( 2023 ) . 2212. Cessation of fluoroquinolone prophylaxis in inpatients with haematological malignancy – a retrospective cohort analysis . Open Forum Infectious Diseases vol. 10 , ( Supplement_2 ) Article ofad500.1834 ,

Vergidis P, Stevens RW, Agrawal SG ( 2023 ) . Antifungal Stewardship Interventions in Patients with Hematologic Malignancies . Current Fungal Infection Reports vol. 17 , ( 2 ) 108 - 118 .

Nelmes E, Chung A, Williams P, Lambourne J, Agrawal S ( 2023 ) . Assessing fever-to- needle times in neutropenic patients at a tertiary haemato-oncology centre . BRITISH JOURNAL OF HAEMATOLOGY . vol. 201 , 146 - 146 .

Agrawal S, Gow N, Wilson D, White L ( 2022 ) . Editorial: Invasive fungal disease in the immunocompromised host/Research Topic proceedings of the mycology 2021 meeting . Frontiers in Cellular and Infection Microbiology vol. 12 , Article 1033739 ,

Mathur A, Sim DS, Choudry F, Veerapen J, Colicchia M, Turlejski T, Hussain M, Hamshere S et al. ( 2022 ) . Five‐year follow‐up of intracoronary autologous cell therapy in acute myocardial infarction: the REGENERATE‐AMI trial . ESC Heart Failure vol. 9 , ( 2 ) 1152 - 1159 .

Caldwell L, Bapat A, Drumright LN, Lambourne J, Jimenez-England FG, Aries J, Eccersley L, Hallam S et al. ( 2022 ) . Cessation of Ciprofloxacin Prophylaxis in Hemato-Oncology Patients . Clinical Infectious Diseases vol. 75 , ( 1 ) 178 - 179 .

Kalia K, O'Neill T, Bapat A, Lambourne J, Agrawal S ( 2022 ) . Fever-to-needle time in the neutropenic cohort: are we meeting the gold-standard? . BRITISH JOURNAL OF HAEMATOLOGY . vol. 197 , 174 - 175 .

Temple S-N, Lazarowicz A, Wilson A, Palmer D, McNamara A, Agrawal S ( 2021 ) . An audit of fever-2-needle time in haemato-oncology patients during COVID-19 . BRITISH JOURNAL OF HAEMATOLOGY . vol. 193 , 81 - 82 .

Caldwell L, Agrawal S, Bapat A, Lambourne J ( 2021 ) . Cessation of ciprofloxacin prophylaxis in haemato-oncology patients at a London teaching hospital . BRITISH JOURNAL OF HAEMATOLOGY . vol. 193 , 230 - 230 .

Farren TW, Sadanand KS, Agrawal SG ( 2020 ) . Highly Sensitive and Accurate Assessment of Minimal Residual Disease in Chronic Lymphocytic Leukemia Using the Novel CD160-ROR1 Assay . Frontiers in Oncology vol. 10 , Article 597730 ,

Aries JA, Davies JK, Auer RL, Hallam SL, Montoto S, Smith M, Sevillano B, Foggo V et al. ( 2020 ) . Clinical outcome of coronavirus disease 2019 in haemato‐oncology patients . British Journal of Haematology vol. 190 , ( 2 )

Muhsen IN, Hashmi SK, Niederwieser D, Kroeger N, Agrawal S, Pasquini MC, Atsuta Y, Ballen KK et al. ( 2019 ) . Correction: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries . Bone Marrow Transplantation vol. 55 , ( 4 ) 837 - 837 .

Muhsen IN, Hashmi SK, Niederwieser D, Kroeger N, Agrawal S, Pasquini MC, Atsuta Y, Ballen KK et al. ( 2019 ) . Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries . Bone Marrow Transplantation vol. 55 , ( 4 ) 698 - 707 .

Schelenz S, Owens K, Guy R, Rautemaa-Richardson R, Manuel RJ, Richardson M, Moore C, Enoch DA et al. ( 2019 ) . National mycology laboratory diagnostic capacity for invasive fungal diseases in 2017: Evidence of sub-optimal practice . Journal of Infection vol. 79 , ( 2 ) 167 - 173 .

( 2019 ) . 13th Annual Fungal Update Conference . Medical Mycology vol. 57 , ( Supplement_3 ) S257 - S258 .

Agrawal S, Vamadevan P, Mazibuko N, Bannister R, Swery R, Wilson S, Edwards S ( 2019 ) . A New Method for Ethical and Efficient Evidence Generation for Off-Label Medication Use in Oncology (A Case Study in Glioblastoma) . Frontiers in Pharmacology vol. 10 , Article 681 ,

Wang H, Jia L, Li Y, Farren T, Agrawal SG, Liu F ( 2019 ) . Increased autocrine interleukin‐6 production is significantly associated with worse clinical outcome in patients with chronic lymphocytic leukemia . Journal of Cellular Physiology vol. 234 , ( 8 ) 13994 - 14006 .

Clear AJ, D'Avola A, Agrawal SG, Rassenti LZ, Kipps TJ, Gribben JG, Riches J ( 2018 ) . B-Cell Receptor Signaling Drives Glycolysis in Chronic Lymphocytic Leukemia Cells . Blood . vol. 132 , 3121 - 3121 .

Agrawal S, Mathieson N, Krendyukov A ( 2018 ) . Sandoz biosimilar filgrastim in stem cell mobilization - a decade of clinical experience . BONE MARROW TRANSPLANTATION . vol. 53 , 785 - 786 .

Micallef C, Ashiru-Oredope D, Hansraj S, Denning DW, Agrawal SG, Manuel RJ, Schelenz S, Guy R et al. ( 2017 ) . An investigation of antifungal stewardship programmes in England . Journal of Medical Microbiology vol. 66 , ( 11 ) 1581 - 1589 .

Cornely OA, Leguay T, Maertens J, Vehreschild MJGT, Anagnostopoulos A, Castagnola C, Verga L, Rieger C et al. ( 2017 ) . Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia . Journal of Antimicrobial Chemotherapy vol. 72 , ( 8 ) 2359 - 2367 .

Cordonnier C, Alanio A, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, Hauser PM, Lagrou K et al. ( 2017 ) . <i>Pneumocystis jirovecii</i>pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients—authors’ response . Journal of Antimicrobial Chemotherapydkw580 - dkw580 .

Taylor JG, Seddon T, Alizadeh K, Agrawal C, Kempster L, Gribben JG, Agrawal SG ( 2017 ) . Single centre experience of ZarzioTM biosimilar Granulocyte-colony stimulating factor (GCSF) for the mobilisation of healthy donors demonstrates good leukapheresis yields and safety profile at 24 month median follow-up . BONE MARROW TRANSPLANTATION . vol. 52 , S145 - S146 .

Tissot F, Agrawal S, Pagano L, Petrikkos G, Groll AH, Skiada A, Lass-Flörl C, Calandra T et al. ( 2016 ) . ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients . Haematologica vol. 102 , ( 3 ) 433 - 444 .

Jones BL, Richardson MD, Ingram PM, Agrawal SG ( 2016 ) . A CONSORT analysis of randomised controlled trials for the treatment of invasive aspergillosis . Medical Mycologymyw133 - myw133 .

Choudhury T, Mozid A, Hamshere S, Yeo C, Pellaton C, Arnous S, Saunders N, Brookman P et al. ( 2016 ) . An exploratory randomized control study of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with ischaemic cardiomyopathy: the <scp>REGENERATE‐IHD</scp> clinical trial . European Journal of Heart Failure vol. 19 , ( 1 ) 138 - 147 .

Agrawal S, Barnes R, Brüggemann RJ, Rautemaa-Richardson R, Warris A ( 2016 ) . The role of the multidisciplinary team in antifungal stewardship . Journal of Antimicrobial Chemotherapy vol. 71 , ( suppl 2 ) ii37 - ii42 .

Liu F-T, Jia L, Wang P, Farren T, Li H, Hao X, Agrawal SG ( 2016 ) . CD126 and Targeted Therapy with Tocilizumab in Chronic Lymphocytic Leukemia . Clinical Cancer Research vol. 22 , ( 10 ) 2462 - 2469 .

Maertens J, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, Alanio A, Hauser PM, Lagrou K et al. ( 2016 ) . ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients . Journal of Antimicrobial Chemotherapy vol. 71 , ( 9 ) 2397 - 2404 .

Alanio A, Hauser PM, Lagrou K, Melchers WJG, Helweg-Larsen J, Matos O, Cesaro S, Maschmeyer G et al. ( 2016 ) . ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients . Journal of Antimicrobial Chemotherapy vol. 71 , ( 9 ) 2386 - 2396 .

Cordonnier C, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, Alanio A, Hauser PM, Lagrou K et al. ( 2016 ) . Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients . Journal of Antimicrobial Chemotherapy vol. 71 , ( 9 ) 2379 - 2385 .

Liu F-T, Jia L, Wang P, Wang H, Farren TW, Agrawal SG ( 2016 ) . STAT3 and NF-κB cooperatively control<i>in vitro</i>spontaneous apoptosis and poor chemo-responsiveness in patients with chronic lymphocytic leukemia . Oncotarget vol. 7 , ( 22 ) 32031 - 32045 .

Halperin D, Hallam S, Haroon A, Butler T, Agrawal S ( 2016 ) . Bing-Neel Syndrome Case Report: A Previously Undocumented IgG Variant with MRI, PET/CT, and PET/MRI Imaging . Case Reports in Hematology vol. 2016 , 1 - 4 .

Nannini F, Parekh F, Jakubowska A, Akarca A, Marafioti T, Chester K, Onuoha S, Agrawal SG et al. ( 2016 ) . Development of novel anti-CD160 CARs . vol. 27 , is. 11 , pp. A85 - A85 .

Choudry F, Hamshere S, Saunders N, Veerapen J, Bavnbek K, Knight C, Pellerin D, Locca D et al. ( 2015 ) . A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial . European Heart Journal vol. 37 , ( 3 ) 256 - 263 .

Hamshere S, Arnous S, Choudhury T, Choudry F, Mozid A, Yeo C, Barrett C, Saunders N et al. ( 2015 ) . Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial . European Heart Journal vol. 36 , ( 44 ) 3061 - 3069 .

Johnson GL, Sarker S-J, Nannini F, Ferrini A, Taylor E, Lass-Flörl C, Mutschlechner W, Bustin SA et al. ( 2015 ) . Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis . Journal of Clinical Microbiology vol. 53 , ( 7 ) 2103 - 2108 .

Wang P, Wang P, Liu B, Zhao J, Pang Q, Agrawal SG, Jia L, Liu F-T ( 2015 ) . Dynamin-related protein Drp1 is required for Bax translocation to mitochondria in response to irradiation-induced apoptosis . Oncotarget vol. 6 , ( 26 ) 22598 - 22612 .

Quinn J, Todd S, Agrawal S, Tsitsikas DA ( 2015 ) . A curious case of facial swelling in the night-time . BMJ vol. 350 , ( apr07 10 ) h1487 - h1487 .

Uddin S, Russell P, Farrell M, Davy B, Taylor J, Agrawal SG ( 2015 ) . Use of biosimilar filgrastim compared with lenograstim in autologous haematopoietic stem-cell transplant and in sibling allogeneic transplant . Therapeutic Advances in Hematology vol. 6 , ( 2 ) 53 - 60 .

Farren TW, Giustiniani J, Fanous M, Liu F, Macey MG, Wright F, Prentice A, Nathwani A et al. ( 2015 ) . Minimal residual disease detection with tumor-specific CD160 correlates with event-free survival in chronic lymphocytic leukemia . Blood Cancer Journal vol. 5 , ( 1 ) e273 - e273 .

Agrawal SG, Dexter TL ( 2015 ) . Cost of antifungal drugs in different haemato-oncology settings . MYCOSES . vol. 58 , 157 - 158 .

Agrawal SG ( 2015 ) . INVASIVE FUNGAL DISEASE MANAGEMENT IN HAEMATO-ONCOLOGY . LEUKEMIA RESEARCH . vol. 39 , SS10 - SS10 .

Bustin SA, Thornton CR, Shannon M, Agrawal SG, Lass-Floerl C, Mutschlechner W, Roberts D, Johnson G ( 2015 ) . Immuno PCR-based assays for the early detection of <i>Aspergillus</i> species . MYCOSES . vol. 58 , 28 - 28 .

Desai N, Nannini F, Agrawal SG ( 2015 ) . Investigating differences in serum and plasma values in galactomannan testing, signal loss and sources of false positivity . BRITISH JOURNAL OF HAEMATOLOGY . vol. 169 , 77 - 77 .

Hamshere S, Arnous S, Choudhury T, Choudry F, Mozid A, Yeo C, Barrett C, Saunders N et al. ( 2015 ) . Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial . EUROPEAN HEART JOURNAL vol. 36 , ( 44 ) 3061 - 3069 .

Johnson GL, Taylor E, Weddell A, Agrawal C, Ready D, Tiberi S, Wyllie S, Sarker SJ et al. ( 2015 ) . TRIADx: A comprehensive and rapid invasive aspergillosis diagnostic testing service for real-time patient management . MYCOSES vol. 58 , 103 - 104 .

Cornely O, Leguay T, Maertens J, Castagnola C, Anagnostopoulos A, Allione B, Heussel CP, Donnelly JP et al. ( 2014 ) . A Double-Blind, Multicentre, Randomised, Placebo-Controlled Study to Assess the Efficacy, Safety and Tolerability of Prophylactic Liposomal Amphotericin B (AmBisome®) for the Prevention of Invasive Fungal Infections in Subjects Receiving Remission-Induction Chemotherapy for Acute Lymphoblastic Leukaemia (AmBiGuard trial) . Blood . vol. 124 , 3646 - 3646 .

Farren TW, Liu F, Le Garff-Tavernier M, Sarfati M, Nauwelaers F, Keenan J, Warner N, Merle-Beral H et al. ( 2014 ) . Soluble CD23 (sCD23): A Forgotten Indicator of Prognosis and Identifier of Outcome in Patients with Chronic Lymphocytic Leukemia Utilizing a Novel Cba Approach . Blood . vol. 124 , 1949 - 1949 .

Johnson GL, Sarker S-J, Bustin SA, Agrawal SG ( 2014 ) . Insufficient Demonstration of Long-Term Stability of Aspergillus Galactomannan . Journal of Clinical Microbiology vol. 52 , ( 11 ) 4118 - 4118 .

Agrawal SG ( 2014 ) . SP-020 DIAGNOSIS, CLINICAL MANAGEMENT AND STEWARDSHIP FOR INVASIVE FUNGAL DISEASE IN HAEMATO-ONCOLOGY . Leukemia Research . vol. 38 , S10 - S10 .

Awan FT, Hillmen P, Hellmann A, Robak T, Hughes SG, Trone D, Shannon M, Flinn IW et al. ( 2014 ) . A randomized, open‐label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab <i>versus</i> fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia . British Journal of Haematology vol. 167 , ( 4 ) 466 - 477 .

Mozid A, Yeo C, Arnous S, Ako E, Saunders N, Locca D, Brookman P, Archbold RA et al. ( 2014 ) . Safety and Feasibility of Intramyocardial Versus Intracoronary Delivery of Autologous Cell Therapy in Advanced Heart Failure: The REGENERATE-IHD Pilot Study . Regenerative Medicine vol. 9 , ( 3 ) 269 - 278 .

Johnson G, Ferrini A, Dolan SK, Nolan T, Agrawal S, Doyle S, Bustin SA ( 2014 ) . Biomarkers for Invasive Aspergillosis: The Challenges Continue . Biomarkers in Medicine vol. 8 , ( 3 ) 429 - 451 .

Hamshere S, Choudhury T, Jones DA, Locca D, Mills P, Rothman M, Knight C, Parmar M et al. ( 2014 ) . A randomised double-blind control study of early intracoronary autologous bone marrow cell infusion in acute myocardial infarction (REGENERATE-AMI) . BMJ Open vol. 4 , ( 2 )

Hamshere S, Choudhury T, Jones DA, Locca D, Mills P, Rothman M, Knight C, Parmar M et al. ( 2014 ) . A randomised double-blind control study of early intracoronary autologous bone marrow cell infusion in acute myocardial infarction (REGENERATE-AMI) . BMJ Open vol. 4 , ( 2 ) e004258 - e004258 .

Renaudon‐Smith E, Gribben JG, Agrawal SG ( 2014 ) . Primary refractory <scp>T</scp>‐cell prolymphocytic leukaemia treated with daily administration of <scp>A</scp>lemtuzumab plus high‐dose methylprednisolone . European Journal of Haematology vol. 92 , ( 4 ) 360 - 361 .

Doffman SR, Agrawal SG, Brown JS ( 2014 ) . Invasive pulmonary aspergillosis . Expert Review of Anti-infective Therapy vol. 3 , ( 4 ) 613 - 627 .

Nannini F, Desai N, Guler S, Agrawal SG ( 2014 ) . MONITORING THE INTRODUCTION OF MICAFUNGIN IN THE DEPARTMENT OF HAEMATO-ONCOLOGY AT BARTS HEALTH NHS TRUST . HAEMATOLOGICA . vol. 99 , 749 - 749 .

Farren TW, Liu F, Agrawal SG ( 2013 ) . Both PI3K p110α and p110δ Isoforms Control CD160-Mediated CLL Cell Viability and Cytokine Production . Blood vol. 122 , ( 21 ) 4124 - 4124 .

Farren TW, Liu F, Macey MG, Kipps TJ, Warner N, Agrawal SG ( 2013 ) . Combined ROR1 and CD160 Detection For Improved Minimal Residual Disease In Patients With Chronic Lymphocytic Leukemia (CLL) . Blood . vol. 122 , 2572 - 2572 .

Agrawal SG, Guy A, O'Flaherty P, Turner M ( 2013 ) . Effectiveness Of Biosimilar Epoetin Alfa For The Treatment Of Chemotherapy-Induced Anemia In Patients With Hematological Malignancies . Blood vol. 122 , ( 21 ) 3430 - 3430 .

Riches JC, Sangaralingam A, Chaplin T, McClanahan F, Iqbal S, Agrawal SG, Ramsay AG, Gribben J ( 2013 ) . NK Cells From CLL Patients Exhibit Down-Regulation Of Interferon Response Genes That Can Be Reversed With Lenalidomide . Blood vol. 122 , ( 21 ) 4131 - 4131 .

Liu F, Jia L, Wang P, Farren T, Agrawal SG ( 2013 ) . Tocilizumab Overcomes Chemo-Resistance Of CLL Cells . Blood . vol. 122 , 5305 - 5305 .

Uddin S, Russell P, Farrell M, Davy B, Agrawal SG ( 2013 ) . Use Of Biosimilar G-CSF Compared With Lenograstim In Autologous Haematopoietic Stem Cell Transplant and In Sibling Allogeneic Transplant . Blood vol. 122 , ( 21 ) 2170 - 2170 .

Gascón P, Tesch H, Verpoort K, Rosati MS, Salesi N, Agrawal S, Wilking N, Barker H et al. ( 2013 ) . Clinical experience with Zarzio® in Europe: what have we learned? . Supportive Care in Cancer vol. 21 , ( 10 ) 2925 - 2932 .

Miraki-Moud F, Anjos-Afonso F, Hodby KA, Griessinger E, Rosignoli G, Lillington D, Jia L, Davies JK et al. ( 2013 ) . Acute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiation . Proceedings of the National Academy of Sciences vol. 110 , ( 33 ) 13576 - 13581 .

Johnson G, Sarker S-J, Hill K, Tsitsikas D, Morin A, Bustin S, Agrawal S ( 2013 ) . Significant Decline in Galactomannan Signal during Storage of Clinical Serum Samples . International Journal of Molecular Sciences vol. 14 , ( 7 ) 12970 - 12977 .

Davies JK, Taussig D, Oakervee H, Smith M, Agrawal S, Cavenagh JD, Gribben JG ( 2013 ) . Long‐term survival with low toxicity after allogeneic transplantation for acute myeloid leukaemia and myelodysplasia using non‐myeloablative conditioning without <scp>T</scp> cell depletion . British Journal of Haematology vol. 162 , ( 4 ) 525 - 529 .

Riches JC, Davies JK, McClanahan F, Fatah R, Iqbal S, Agrawal S, Ramsay AG, Gribben JG ( 2013 ) . T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production . Blood vol. 121 , ( 9 ) 1612 - 1621 .

Mozid AM, Jones D, Arnous S, Saunders N, Wragg A, Martin J, Agrawal S, Mathur A ( 2013 ) . The Effects of Age, Disease State, and Granulocyte Colony-Stimulating Factor on Progenitor Cell Count and Function in Patients Undergoing Cell Therapy for Cardiac Disease . Stem Cells and Development vol. 22 , ( 2 ) 216 - 223 .

Nizam A, Heath A, Fanous M, Dark L, Agrawal S ( 2013 ) . AUDIT OF POSACONAZOLE USAGE IN THE HAEMATO-ONCOLOGY UNIT AT ST BARTHOLOMEW'S HOSPITAL . HAEMATOLOGICA . vol. 98 , 186 - 186 .

Ferrini A, Johnson GL, Agrawal SG, Bustin SA ( 2013 ) . Development of a MIQE-compliant <i>Aspergillus terreus</i> specific qPCR assay . MYCOSES vol. 56 , 78 - 78 .

Johnson GL, Shannon M, Thornton CR, Agrawal SG, Bustin SA ( 2013 ) . Proximity ligation assay for the sensitive, specific and early diagnosis of invasive fungal disease . MYCOSES vol. 56 , 48 - 49 .

Riches JC, Davies JK, McClanahan F, Fatah R, Iqbal S, Agrawal S, Ramsay AG, Gribben JG ( 2012 ) . Characterizing Immunophenotypic and Functional Pseudo-Exhaustion in T Cells From CLL Patients: The Impact of Lenalidomide . Blood vol. 120 , ( 21 ) 564 - 564 .

Pang Q, Liu N, Liu F, Agrawal S, Wang P ( 2012 ) . Drp1 Activation Overcomes Diffuse Large B-Cell Lymphoma Cells Radioresistance . Blood . vol. 120 , 5121 - 5121 .

Johnson GL, Bibby DF, Wong S, Agrawal SG, Bustin SA ( 2012 ) . A MIQE-Compliant Real-Time PCR Assay for Aspergillus Detection . PLoS ONE vol. 7 , ( 7 ) e40022 - e40022 .

Tsitsikas DA, Morin A, Araf S, Murtagh B, Johnson G, Vinnicombe S, Ellis S, Suaris T et al. ( 2012 ) . Impact of the revised (2008) EORTC/MSG definitions for invasive fungal disease on the rates of diagnosis of invasive aspergillosis . Medical Mycology vol. 50 , ( 5 ) 538 - 542 .

Agrawal SG, Mather SJ ( 2012 ) . Pathogen identification by nuclear imaging – almost there? . European Journal of Nuclear Medicine and Molecular Imaging vol. 39 , ( 7 ) 1173 - 1174 .

Pettitt AR, Jackson R, Carruthers S, Dodd J, Dodd S, Oates M, Johnson GG, Schuh A et al. ( 2012 ) . Alemtuzumab in Combination With Methylprednisolone Is a Highly Effective Induction Regimen for Patients With Chronic Lymphocytic Leukemia and Deletion of <i>TP53</i>: Final Results of the National Cancer Research Institute CLL206 Trial . Journal of Clinical Oncology vol. 30 , ( 14 ) 1647 - 1655 .

Shamash J, Jacob J, Agrawal S, Powles T, Mutsvangwa K, Wilson P, Stebbing J ( 2012 ) . Whole Blood Stem Cell Reinfusion and Escalated Dose Melphalan in Castration-Resistant Prostate Cancer: A Phase 1 Study . Clinical Cancer Research vol. 18 , ( 8 ) 2352 - 2359 .

Auer RL, MacDougall F, Oakervee HE, Taussig D, Davies JK, Syndercombe‐Court D, Agrawal S, Cavenagh JD et al. ( 2012 ) . <scp>T</scp>‐cell replete fludarabine/cyclophosphamide reduced intensity allogeneic stem cell transplantation for lymphoid malignancies . British Journal of Haematology vol. 157 , ( 5 ) 580 - 585 .

Thornton C, Johnson G, Agrawal S ( 2012 ) . Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology . Journal of Visualized Experiments ( 61 )

Agrawal S, Jones B, Barnes R, Kibbler C, Millen M, Ashcroft M, Jain S, Last A et al. ( 2012 ) . A practical critique of antifungal treatment guidelines for haemato-oncologists . Critical Reviews in Microbiology vol. 38 , ( 3 ) 203 - 216 .

Joshi NM, Hassan S, Jasani P, Dixon S, Cavenagh JD, Oakervee HE, Smith M, Agrawal SA et al. ( 2012 ) . Bile acid malabsorption in patients with graft‐versus‐host disease of the gastrointestinal tract . British Journal of Haematology vol. 157 , ( 3 ) 403 - 407 .

Liu F, Jia L, Farren T, Gribben J, Agrawal S ( 2012 ) . AUTOCRINE IL-6 PRODUCTION CORRELATED WITH SURVIVAL OF CHRONIC LYMPHOCYTIC LEUKAEMIA CELLS . HAEMATOLOGICA . vol. 97 , 517 - 517 .

Farren W, Fanous M, Liu F, Macey M, Jenner M, Agrawal S ( 2012 ) . EARLY DETECTION OF MINIMAL RESIDUAL DISEASE DETECTION TARGETING CD160 IN CHRONIC LYMPHOCYTIC LEUKAEMIA PREDICTS PROGRESSION FREE SURVIVAL AND CORRELATES WITH BIOLOGICAL PROGNOSTIC RISK GROUPS . HAEMATOLOGICA . vol. 97 , 291 - 291 .

Riches J, Davies J, McClanahan F, Iqbal S, Fatah R, Agrawal S, Ramsay A, Gribben J ( 2012 ) . IDENTIFICATION OF AN EXPANDED POPULATION OF TERMINALLY DIFFERENTIATED CD8+T CELLS WITH A NOVEL PHENOTYPIC AND FUNCTIONAL PROFILE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA . HAEMATOLOGICA . vol. 97 , 451 - 451 .

Bustin SA, Johnson G, Agrawal SG ( 2012 ) . MIQE - guidelines for developing robust real-time PCR assays . MYCOSES vol. 55 , 30 - 30 .

Gascon P, Tesch H, Verpoort K, Rosati MS, Salesi N, Barker H, Agrawal S, Muenzberg M et al. ( 2012 ) . USE OF BIOSIMILAR G-CSF FOR PREVENTION OF CHEMOTHERAPY-INDUCED NEUTROPENIA: POOLED ANALYSIS OF CLINICAL USAGE STUDIES . ANNALS OF ONCOLOGY . vol. 23 , 502 - 503 .

Liu F, Jia L, Farren TW, Gribben JG, Agrawal SG ( 2011 ) . Autocrine IL-6 Production Indicates the Level of Activated STAT3 and NF-Kb of Chronic Lymphocytic Leukemia Cells . Blood vol. 118 , ( 21 ) 1784 - 1784 .

Farren TW, Liu F, Macey M, Jenner M, Agrawal S ( 2011 ) . Early Detection of Minimal Residual Disease in Biological Prognostic Risk Groups in Chronic Lymphocytic Leukaemia (CLL) Utilizing the Novel CD160FCA Assay . Blood vol. 118 , ( 21 ) 2832 - 2832 .

Riches JC, Davies J, Iqbal S, Fatah R, Agrawal S, Ramsay AG, Gribben JG ( 2011 ) . T-Cells From Patients with CLL Exhibit Phenotypic and Transcription Factor Profiles of Exhaustion Independent of CMV Serostatus . Blood vol. 118 , ( 21 ) 1780 - 1780 .

Sinha S, Farren TW, Grantham M, Agrawal S ( 2011 ) . The Prognostic Significance of Monoallelic Versus Biallelic 13q Deletions in Patients with Chronic Lymphocytic Leukemia, . Blood vol. 118 , ( 21 ) 3893 - 3893 .

Liu F, Jia L, Farren T, Gribben J, Agrawal S ( 2011 ) . 2.21 Autocrine Interleukin-6 Production Correlated with Survival of Chronic Lymphocytic Leukaemia Cells . Clinical Lymphoma Myeloma and Leukemia vol. 11 , S172 - S172 .

Liu F, Jia L, Farren T, Gribben J, Agrawal S ( 2011 ) . 2.46 Signal Transducer and Activator of Transcription 3 and Nuclear Factor κB Activation Regulate Autocrine Interleukin-6 Production and Indicate the Prognosis of CLL . Clinical Lymphoma Myeloma and Leukemia vol. 11 , S188 - S189 .

Araf S, Tsitsikas DA, Stevenson J, Agrawal SG ( 2011 ) . 3.17 Similar Rates of Invasive Fungal Disease in CLL and ‘High-Risk' Acute Myeloid Leukaemia/Allogeneic Transplant Patients . Clinical Lymphoma Myeloma and Leukemia vol. 11 , S207 - S208 .

Farren T, Liu F, Macey M, Jenner M, Prentice A, Nathwani A, Agrawal SG ( 2011 ) . 4.17 A Novel Approach to Minimal Residual Disease Assessment in Chronic Lymphocytic Leukaemia Utilizing the Tumour Specific Antigen CD160 . Clinical Lymphoma Myeloma and Leukemia vol. 11 , S228 - S229 .

Sinhal S, Farren T, Grantham M, Butler T, Agrawal S ( 2011 ) . 4.26 Monoallelic versus Biallelic 139 Deletion in B-CLL May Confer a Poorer Prognosis . Clinical Lymphoma Myeloma and Leukemia vol. 11 , S236 - S237 .

Farren TW, Giustiniani J, Liu FT, Tsitsikas DA, Macey MG, Cavenagh JD, Oakervee HE, Taussig D et al. ( 2011 ) . Differential and tumor-specific expression of CD160 in B-cell malignancies . BLOOD vol. 118 , ( 8 ) 2174 - 2183 .

Shamash J, Jacob J, Powles T, Agrawal S, Mutsvangwa K, Saunders N, Wilson P, Stebbing J ( 2011 ) . Melphalan and whole-blood stem cell reinfusion in castration-resistant prostate cancer (CRPC): A phase I/II study . Journal of Clinical Oncology vol. 29 , ( 15_suppl ) 2573 - 2573 .

Shamash J, Jacob J, Powles T, Agrawal S, Mutsvangwa K, Saunders N, Wilson P, Stebbing J ( 2011 ) . Melphalan and whole-blood stem cell reinfusion in castration-resistant prostate cancer (CRPC): A phase I/II study . Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 29 , ( 15_suppl )

Powles T, Chowdhury S, Shamash J, Bazeos A, Gillessen S, Saunders N, Lim L, Sarwar N et al. ( 2011 ) . Increased haematopoietic progenitor cells are associated with poor outcome in patients with metastatic renal cancer treated with sunitinib . ANN ONCOL vol. 22 , ( 4 ) 815 - 820 .

Liu F, Jia L, Farren TW, Gribben JG, Agrawal SG ( 2011 ) . Autocrine IL-6 Production Indicates the Level of Activated STAT3 and NF-Kb of Chronic Lymphocytic Leukemia Cells . BLOOD . vol. 118 , 778 - 778 .

Farren TW, Liu F, Macey MG, Jenner M, Prentice A, Nathwani A, Agrawal SG ( 2011 ) . CD160: a novel approach to minimal residual disease (MRD) assessment in chronic lymphocytic leukaemia (CLL) . BRITISH JOURNAL OF HAEMATOLOGY . vol. 153 , 72 - 72 .

Johnson GL, Hill K, Agrawal S ( 2011 ) . Decline in detectable galactomannan levels during storage of serum samples . MYCOSES vol. 54 , 53 - 53 .

Johnson GL, Bibby D, Bustin S, Thornton C, Agrawal S ( 2011 ) . Detection of <i>Aspergillus</i> in broncho-alveolar lavage fluid using two biological assays; evidence of active infection? . MYCOSES vol. 54 , 130 - 131 .

Agrawal SG ( 2011 ) . ECIL vs. IDSA guidelines . MYCOSES vol. 54 , 41 - 42 .

Farren TW, Liu F, Macey M, Jenner M, Agrawal S ( 2011 ) . Early Detection of Minimal Residual Disease in Biological Prognostic Risk Groups in Chronic Lymphocytic Leukaemia (CLL) Utilizing the Novel CD160FCA Assay . BLOOD . vol. 118 , 1220 - 1220 .

Johnson G, Bustin SA, Agrawal S ( 2011 ) . Efficient detection of <i>Aspergillus</i> DNA from broncho-alveolar lavage fluid of infected acute leukaemia patients . BRITISH JOURNAL OF HAEMATOLOGY . vol. 153 , 56 - 56 .

Mozid A, Arnous S, Yeo C, Brookman P, Preston M, Archbold A, Rothman M, Agrawal S et al. ( 2011 ) . Head-to-head comparison of different delivery methods of autologous bone marrow progenitor cells in chronic ischaemic heart failure . EUROPEAN HEART JOURNAL vol. 32 , 456 - 456 .

Agrawal S, Hope W, Sinko J, Kibbler C ( 2011 ) . Optimizing management of invasive mould diseases . J ANTIMICROB CHEMOTH vol. 66 , i45 - i53 .

Riches JC, Davies J, Iqbal S, Fatah R, Agrawal S, Ramsay AG, Gribben JG ( 2011 ) . T-Cells From Patients with CLL Exhibit Phenotypic and Transcription Factor Profiles of Exhaustion Independent of CMV Serostatus . BLOOD . vol. 118 , 776 - 777 .

Sinha S, Farren TW, Grantham M, Agrawal S ( 2011 ) . The Prognostic Significance of Monoallelic Versus Biallelic 13q Deletions in Patients with Chronic Lymphocytic Leukemia . BLOOD . vol. 118 , 1663 - 1664 .

Tsitsikas DA, Sibony DW, Oakervee HE, Agrawal SG, Smith M, Taussig DC, de Vos J, Stewart E et al. ( 2010 ) . A Phase II Trial of Sequential Treatment with Cytoreductive Therapy and Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukaemia, High Risk MDS and Other High Risk Myeoid Malignancies An Interim Report . BLOOD . vol. 116 , 1430 - 1430 .

Tsitsikas DA, Warcel-Sibony D, Oakervee HE, Agrawal SG, Smith M, Taussig DC, de Vos J, Stewart E et al. ( 2010 ) . A Phase II Trial of Sequential Treatment with Cytoreductive Therapy and Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukaemia, High-Risk MDS and Other High Risk Myeoid Malignancies: An Interim Report . Blood vol. 116 , ( 21 ) 3480 - 3480 .

Liu F, Jia L, Farren T, Gribben JG, Agrawal S ( 2010 ) . Autocrine IL6/STAT3 Signaling Enhances Survival of Chronic Lymphocytic Leukaemia Cells . Blood vol. 116 , ( 21 ) 3598 - 3598 .

Farren T, Liu FT, Stephens C, Macey M, Jenner M, Prentice A, Nathwani A, Agrawal S ( 2010 ) . Inter Laboratory Assessment of Minimal Residual Disease In Chronic Lymphocytic Leukemia - Evaluation of the Novel CD160FCA Assay . BLOOD . vol. 116 , 1122 - 1123 .

Farren T, Liu F, Stephens C, Macey M, Jenner M, Prentice A, Nathwani A, Agrawal S ( 2010 ) . Inter-Laboratory Assessment of Minimal Residual Disease In Chronic Lymphocytic Leukemia – Evaluation of the Novel CD160FCA Assay . Blood vol. 116 , ( 21 ) 2723 - 2723 .

Tsitsikas DA, Vinicombe S, Sheaff M, Ellis S, Rizvi H, Manuel R, Agrawal SG ( 2010 ) . A patient with CLL and a dry cough . BMJ vol. 340 , ( jun30 1 ) c3051 - c3051 .

Chowdhury S, O’Brien TS, Sarwar N, Shamash J, McGrath S, Agrawal S, Lim L, Rudman SM et al. ( 2010 ) . The effect of sunitinib on immune parameters and haemopoetic stem cell markers in patients with untreated clear cell renal cancer . Journal of Clinical Oncology vol. 28 , ( 15_suppl ) 4620 - 4620 .

Liu FT, Giustiniani J, Farren T, Jia L, Bensussan A, Gribben JG, Agrawal SG ( 2010 ) . CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia . BLOOD vol. 115 , ( 15 ) 3079 - 3088 .

Taussig DC, Vargaftig J, Miraki-Moud F, Griessinger E, Sharrock K, Luke T, Lillington D, Oakervee H et al. ( 2010 ) . Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction . BLOOD vol. 115 , ( 10 ) 1976 - 1984 .

Macey MG, Bevan S, Alam S, Verghese L, Agrawal S, Beski S, Thuraisingham R, MacCallum PK ( 2010 ) . Platelet activation and endogenous thrombin potential in pre-eclampsia . THROMB RES vol. 125 , ( 3 ) E76 - E81 .

Tsitsikas DA, Warcel-Sibony D, Oakervee HE, Agrawal SG, Smith M, Taussig DC, de Vos J, Stewart E et al. ( 2010 ) . A Phase II Trial of Sequential Treatment with Cytoreductive Therapy and Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukaemia, High-Risk MDS and Other High Risk Myeoid Malignancies: An Interim Report . BLOOD . vol. 116 , 1430 - 1430 .

Liu F, Jia L, Farren T, Gribben JG, Agrawal S ( 2010 ) . Autocrine IL6/STAT3 Signaling Enhances Survival of Chronic Lymphocytic Leukaemia Cells . BLOOD . vol. 116 , 1481 - 1481 .

Farren T, Liu F, Stephens C, Macey M, Jenner M, Prentice A, Nathwani A, Agrawal S ( 2010 ) . Inter-Laboratory Assessment of Minimal Residual Disease In Chronic Lymphocytic Leukemia-7 Evaluation of the Novel CD160FCA Assay . BLOOD . vol. 116 , 1122 - 1123 .

Farren TW, Liu F-T, Stephens C, Tsitsikas D, Macey MG, Jenner M, Gribben JG, Agrawal SG ( 2009 ) . CD160 Expression in B-Cell Lymphoproliferative Disorders: Derivation and Validation of a New Three-Antigen Scoring System Improving Diagnostic Precision in B-Cell Malignancies . Blood vol. 114 , ( 22 ) 4382 - 4382 .

Butler T, Wiseman C, Farren T, Gribben JG, Agrawal SG ( 2009 ) . Expression of Surface IgG Is High in Chronic Lymphocytic Leukaemia, and Co-Expression with IgM Confers a Worse Prognosis . Blood vol. 114 , ( 22 ) 4371 - 4371 .

Liu F-T, Jia L, Farren T, Giustiniani J, Bensussan A, Gribben JG, Agrawal SG ( 2009 ) . Spontaneous in Vitro Death of CLL Cells Can Be Prevented by Mitochondrial Stabilization Via CD160 Signaling . Blood vol. 114 , ( 22 ) 4372 - 4372 .

Lambourne J, Agranoff D, Herbrecht R, Troke PF, Buchbinder A, Willis F, Letscher-Bru V, Agrawal S et al. ( 2009 ) . Association of Mannose-Binding Lectin Deficiency with Acute Invasive Aspergillosis in Immunocompromised Patients . CLIN INFECT DIS vol. 49 , ( 10 ) 1486 - 1491 .

Yeo C, Saunders N, Locca D, Flett A, Preston M, Brookman P, Davy B, Mathur A et al. ( 2009 ) . Ficoll-Paque™ Versus Lymphoprep™: A Comparative Study of two Density Gradient Media for Therapeutic Bone Marrow Mononuclear Cell Preparations . Regenerative Medicine vol. 4 , ( 5 ) 689 - 696 .

Tsitsikas DA, Oakervee H, Cavenagh JD, Gribben J, Agrawal SG, Mattes FM ( 2009 ) . Treatment of respiratory syncytial virus infection in haemopoietic stem cell transplant recipients with aerosolized ribavirin and the humanized monoclonal antibody palivizumab: a single centre experience . BRIT J HAEMATOL vol. 146 , ( 5 ) 574 - 576 .

Yeo C, Locca D, Wong J, Saunders N, Preston M, Brookman T, Archbold A, Rothman M et al. ( 2009 ) . EJECTION FRACTION AND NYHA CLASS IN HEART FAILURE IN THE REGENERATE-IHD STEM CELL STUDY: A COMPARISON BETWEEN THE INTRAMYOCARDIAL AND INTRACORONARY ARMS . HEART . vol. 95 , A70 - A70 .

Yeo C, Locca D, Wong J, Burchell T, Preston M, Brookman P, Hipperson D, Archbold A et al. ( 2009 ) . Ejection Fraction and NYHA Class in Heart Failure in the REGENERATE-IHD Stem Cell Study: a Comparison Between the Intramyocardial and Intracoronary Arms . AMERICAN JOURNAL OF CARDIOLOGY . vol. 104 , 190D - 191D .

Hassan S, Leung M, Ridler C, Stephens C, Macey M, Jenner M, Agrawal S ( 2009 ) . FLT3 ANTIGEN EXPRESSION IN ACUTE LEUKAEMIA USING FLOW CYTOMETRY . HAEMATOLOGICA-THE HEMATOLOGY JOURNAL . vol. 94 , 117 - 117 .

Pettitt R, Matutes E, Dearden C, Oscier D, Carruthers S, Dodd J, Dodd S, Jones R et al. ( 2009 ) . RESULTS OF THE PHASE II NCRI CLL206 TRIAL OF ALEMTUZUMAB IN COMBINATION WITH HIGH-DOSE METHYLPREDNISOLONE FOR HIGH-RISK (17P-) CLL . HAEMATOLOGICA-THE HEMATOLOGY JOURNAL . vol. 94 , 138 - 139 .

Tsitsikas DA, Morin A, Murtagh B, Athorn G, Suaris T, Ellis S, Vinnicombe S, Wilks M et al. ( 2009 ) . Significant reduction in the diagnosis of possible and probable invasive fungal infection by applying the revised EORTC definitions of invasive fungal disease . BONE MARROW TRANSPLANTATION . vol. 43 , S46 - S46 .

Matin RN, Agrawal SG, Jenner M, Cerio R, Rizvi H, Harwood CA ( 2009 ) . Splenic B-cell marginal zone lymphoma presenting in the skin . BRITISH JOURNAL OF DERMATOLOGY . vol. 161 , 89 - 89 .

Tsitsikas DA, Oakervee H, Cavenagh J, Agrawal S, Gribben J, Mattes F ( 2009 ) . Treatment of respiratory syncytial virus infection with nebulised ribavirin and the humanised monoclonal antibody palivizumab in eight haemopoietic stem cell transplant recipients . BONE MARROW TRANSPLANTATION . vol. 43 , S252 - S253 .

Agrawal SRG, Liu F-T, Giustiniani J, Jia L, Gribben JG, Bensussan A ( 2008 ) . Dual Action of CD160 on CLL Cells: Giving Life to Prepare for Death! . Blood vol. 112 , ( 11 ) 2088 - 2088 .

Liu FT, Agrawal SG, Movasaghi Z, Wyatt PB, Rehman IU, Gribben JG, Newland AC, Jia L ( 2008 ) . Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib . BLOOD vol. 112 , ( 9 ) 3835 - 3846 .

Taussig DC, Miraki-Moud F, Anjos-Afonso F, Pearce DJ, Allen K, Ridler C, Lillington D, Oakervee H et al. ( 2008 ) . Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells . BLOOD vol. 112 , ( 3 ) 568 - 575 .

Khanna P, Doffman S, Griffiths L, Wareham D, Agrawal SG, Das S ( 2008 ) . A case of febrile neutropenia with a skin rash . Journal of Infection vol. 56 , ( 4 ) 309 - 309 .

Liu FT, Agrawal SG, Gribben JG, Ye HT, Du MQ, Newland AC, Jia L ( 2008 ) . Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL . BLOOD vol. 111 , ( 5 ) 2797 - 2805 .

Agrawal SG, Liu FT, Wiseman C, Shirali S, Liu H, Lillington D, Du MQ, Syndercombe-Court D et al. ( 2008 ) . Increased proteasomal degradation of Bax is a common feature of poor prognosis chronic lymphocytic leukemia . BLOOD vol. 111 , ( 5 ) 2790 - 2796 .

Davies CEF, Whitelocke RAF, Agrawal S ( 2008 ) . Retinal complications associated with hyperviscosity in chronic lymphocytic leukaemia . Internal Medicine Journal vol. 38 , ( 2 ) 140 - 140 .

Malyszczak W, Jones BL, Jackson B, Malyszczak W, Agrawal S, Jensen M ( 2008 ) . COST COMPARISON OF LIPOSOMAL AMPHOTERICIN B VS CASPOFUNGIN FOR THE EMPIRICAL TREATMENT OF INVASIVE FUNGAL INFECTIONS . HAEMATOLOGICA-THE HEMATOLOGY JOURNAL . vol. 93 , 321 - 321 .

Agrawal SG, Liu F-T, Giustiniani J, Jia L, Gribben JG, Bensussan A ( 2008 ) . Dual Action of CD160 on CLL Cells: Giving Life to Prepare for Death! . BLOOD . vol. 112 , 726 - 726 .

Bevan S, Beski S, Thuraisingham R, Agrawal S, Barnes I, Alam S, Verghese L ( 2008 ) . Preeclampsia - risk assessment . BRITISH JOURNAL OF HAEMATOLOGY . vol. 141 , 64 - 64 .

Bevan S, Beski S, Thuraisingham R, Agrawal S, Barnes I, Alam S, Verghese L ( 2008 ) . The endogenous thrombin potential has high positive predictive value for recurrent unprovoked venous thrombosis in the second Cambridge prospective cohort study . BRITISH JOURNAL OF HAEMATOLOGY . vol. 141 , 64 - 65 .

Thorogood N, Atwal S, Mills W, Jenner M, Lewis DA, Cavenagh JD, Agrawal SG ( 2007 ) . The risk of antimalarials in patients with renal failure . Postgraduate Medical Journal vol. 83 , ( 986 ) 8 - 8 .

Greaves P, Agrawal S ( 2007 ) . Safe and efficacious use of recombinant human erythropoietin in malignancy . CLIN MED vol. 7 , ( 6 ) 617 - 620 .

Doffman SR, Griffiths LJ, Lim C, Vinnicombe S, Wilks M, Gribben JG, Griffiths MJ, Agrawal SG ( 2007 ) . A Novel Non-Invasive Method of Detecting Galactomannan in Suspected Pulmonary Aspergillosis . Blood vol. 110 , ( 11 ) 3862 - 3862 .

Agrawal SG, Liu F-T, Wiseman C, Shirali S, Liu H, Lillington D, Du MQ, Court DS et al. ( 2007 ) . Bax Degradation Activity Is a Novel Poor Prognosis Marker of Chronic Lymphocytic Leukemia . Blood . vol. 110 , 3087 - 3087 .

Giustiniani J, Wiseman C, Farren T, Gribben JG, Agrawal SG ( 2007 ) . CLL Cell Proliferation and IL-6 Production Are Regulated by CD160 - MHC Class I Interactions Offering New Therapeutic Targets . Blood . vol. 110 , 1126 - 1126 .

Wiseman C, Giustiniani J, Mikkelsen L, Macey M, Goff L, Gribben J, Agrawal S ( 2007 ) . High Frequency of Surface Immunoglobulin IgG in B-Cell Chronic Lymphocytic Leukaemia . Blood . vol. 110 , 4685 - 4685 .

Tsitsikas DA, Giustiniani J, Skipper A, Ebrahim F, Johannson U, Macey M, Jenner M, Newland AC et al. ( 2007 ) . Universal CD160 Expression and the CD5+23+ / CD5+19+ Ratio in Chronic Lymphocytic Leukemia Simplfy Identification of Atypical Cases from CD23+ Mantle Cell Lymphoma . Blood . vol. 110 , 4678 - 4678 .

Farren T, Giustiniani J, Johansson U, Lim C, Athorn G, Newland A, Macey M, Agrawal S ( 2007 ) . Using CD160 as a Novel Approach to the Assessment of Minimal Residual Disease (MRD) in Chronic Lymphocytic Leukaemia (CLL) . Blood vol. 110 , ( 11 ) 2036 - 2036 .

Poole C, Agrawal S, Currie CJ ( 2007 ) . Nice transparency - Let cost effectiveness models be open to scrutiny . BRIT MED J vol. 335 , ( 7623 ) 735 - 735 .

Doffman SR, Griffiths LJ, Lim C, Vinnicombe S, Wilks M, Gribben JG, Griffiths MJ, Agrawal SG ( 2007 ) . A novel non-invasive method of detecting galactomannan in suspected pulmonary aspergillosis . BLOOD . vol. 110 , 33B - 33B .

Doffman SR, Griffiths LJ, Athorn GR, Vinnicombe SJ, Moore-Gillon JC, Griffiths MJ, Agrawal SG ( 2007 ) . Galactomannan detection in exhaled breath condensate of neutropenic patients with suspected invasive pulmonary aspergillosis . THORAX . vol. 62 , A50 - A51 .

Greaves P, Agrawal S, Lim C, Poole C ( 2007 ) . Intravenous iron improves response rates to recombinant human erythropoietin in anaemic patients with haematological malignancy on chemotherapy which iron parameters to use? . HAEMATOLOGICA-THE HEMATOLOGY JOURNAL . vol. 92 , 28 - 28 .

Farren T, Giustiniani J, Johansson U, Lim C, Athorn G, Newland A, Macey M, Agrawal S ( 2007 ) . Using CD160 as a novel approach to the assessment of minimal residual disease (MRD) in chronic lymphocytic leukaemia (CLL) . BLOOD . vol. 110 , 606A - 606A .

Agrawal SG, Greaves P, Lim C, Poole CD, Walker MD ( 2006 ) . Optimising Haemoglobin Response to Exogenous Erythropoietin in Anaemic Patients Treated in Routine Haemato-Oncology Practice . Blood . vol. 108 , 5516 - 5516 .

Knapper S, Burnett AK, Littlewood T, Kell WJ, Agrawal S, Chopra R, Clark R, Levis MJ et al. ( 2006 ) . A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy . BLOOD vol. 108 , ( 10 ) 3262 - 3270 .

Dulic-Sills A, Blunden MJ, Mawdsley J, Bastin AJ, McAuley D, Griffiths M, Rampton DS, Yaqoob MM et al. ( 2006 ) . New flow cytometric technique for the evaluation of circulating endothelial progenitor cell levels in various disease groups . J IMMUNOL METHODS vol. 316 , ( 1-2 ) 107 - 115 .

Agrawal S, Davidson N, Walker M, Gibson S, Lim C, Morgan CL, Cowell W ( 2006 ) . Assessing the total costs of blood delivery to hospital oncology and haematology patients . CURR MED RES OPIN vol. 22 , ( 10 ) 1903 - 1909 .

Dulic-Sills A, Blunden MJ, Mawdsley J, Bastin AJ, McAuley D, Griffiths M, Rampton DS, Yaqoob MM et al. ( 2006 ) . New flow cytometric technique for the evaluation of circulating endothelial progenitor cell levels in various disease groups . Journal of Immunological Methods vol. 316 , ( 1-2 ) 107 - 115 .

Griffiths LJ, Anyim M, Doffman SR, Wilks M, Millar MR, Agrawal SG ( 2006 ) . Comparison of DNA extraction methods for Aspergillus fumigatus using real-time PCR . J MED MICROBIOL vol. 55 , ( 9 ) 1187 - 1191 .

Davies JK, Taussig DC, Oakervee H, Davies AJ, Agrawal SG, Gribben JG, Lister TA, Cavenagh JD ( 2006 ) . Long-Term Follow-Up After Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia/Myelodysplastic Syndrome: Late CNS Relapses Despite Graft-Versus-Host Disease . Journal of Clinical Oncology vol. 24 , ( 14 ) e23 - e25 .

Quint J, Mills W, Lewis D, Cavenagh JD, Agrawal SG ( 2006 ) . A complication of steroid therapy in acute leukaemia - A case report . HEMATOLOGY vol. 11 , ( 2 ) 97 - 99 .

Mills KI, Walsh V, Gilkes AF, Agrawal SG, Knapper S ( 2006 ) . Novel observation of three FLT3 codons mutated in tandem in an elderly acute myeloid leukaemia patient (vol 132, pg 116, 2006) . BRIT J HAEMATOL vol. 132 , ( 5 ) 663 - 663 .

Ansari N, Popat R, Lim C, Cavill I, Agrawal SG ( 2006 ) . High response rates to erythropoietin therapy for chemotherapy-associated anaemia using targeted intravenous iron supplementation . BRITISH JOURNAL OF HAEMATOLOGY . vol. 133 , 34 - 35 .

Popat R, Oakervee H, Curry N, Foot N, Morris C, Drake M, Agrawal S, Odeh L et al. ( 2006 ) . Low dose PAD combination therapy (PS-341/bortezomib, adriamycin and dexamethasone) for untreated multiple myeloma . BRITISH JOURNAL OF HAEMATOLOGY . vol. 133 , 99 - 99 .

Popat R, Oakervee HE, Foot N, Agrawal S, Odeh L, Craddock C, Williams C, Basu S et al. ( 2006 ) . Low dose intravenous melphalan and bortezomib for relapsed multiple myeloma . BRITISH JOURNAL OF HAEMATOLOGY . vol. 133 , 98 - 98 .

Mills KI, Walsh V, Gilkes AF, Agrawal SG, Knapper S ( 2005 ) . Novel observation of three FLT3 codons mutated in tandem in an elderly acute myeloid leukaemia patient . British Journal of Haematology vol. 132 , ( 1 ) 116 - 117 .

Popat R, Oakervee HE, Foot N, Agrawal S, Smith P, Craddock C, Williams C, Basu S et al. ( 2005 ) . A Phase I/II Study of Bortezomib and Low Dose Intravenous Melphalan (BM) for Relapsed Multiple Myeloma . Blood vol. 106 , ( 11 ) 2555 - 2555 .

Agrawal SG, Lim C, Cavill I ( 2005 ) . Prospective Targeted Epoietin beta Therapy for Chemotherapy-Associated Anaemia Achieves High Response Rates . Blood vol. 106 , ( 11 ) 588 - 588 .

Popat R, Oakervee HE, Curry N, Foot N, Morris C, Drake M, Agrawal S, Smith P et al. ( 2005 ) . Reduced Dose PAD Combination Therapy (PS-341/Bortezomib, Adriamycin and Dexamethasone) for Previously Untreated Patients with Multiple Myeloma . Blood vol. 106 , ( 11 ) 2554 - 2554 .

Oakervee HE, Popat R, Curry N, Smith P, Morris C, Drake M, Agrawal S, Stec J et al. ( 2005 ) . PAD combination therapy (PS‐341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma . British Journal of Haematology vol. 129 , ( 6 ) 755 - 762 .

Popat R, Oakervee HE, Foot N, Agrawal S, Smith P, Craddock C, Williams C, Basu S et al. ( 2005 ) . A phase I/II study of bortezomib and low dose intravenous melphalan (BM) for relapsed multiple myeloma . BLOOD . vol. 106 , 718A - 718A .

Popat R, Oakervee HE, Agrawal S, Smith P, Singer C, Craddock C, Williams C, Wylde P et al. ( 2005 ) . A phase I/II trial of bortezomib and low dose intravenous melphalan (BM) for relapsed multiple myeloma . BRITISH JOURNAL OF HAEMATOLOGY . vol. 129 , 27 - 27 .

Rintala T, Ritchie L, Goodwin S, Delgado-Gonzalez J, Agrawal S ( 2005 ) . Allogeneic donor safety: addressing JACIE . BONE MARROW TRANSPLANTATION . vol. 35 , S288 - S289 .

Blunden MJ, Dulic-Sills A, Yaqoob MM, Agrawal S, Macey MG ( 2005 ) . Endothelial progenator cells are reduced in patients with chronic kidney disease, especailly those with pre-existing cardiovascular disease, compared to healthy individuals . CYTOMETRY PART B-CLINICAL CYTOMETRY . vol. 68B , 54 - 55 .

Popat R, Oakervee H, Foot N, Curry N, Morris C, Drake M, Agrawal S, Smith P et al. ( 2005 ) . PAD (PS-341/bortezomib, adriamycin and dexamethasone) as front-line therapy for untreated patients with multiple myeloma . BRITISH JOURNAL OF HAEMATOLOGY . vol. 129 , 22 - 22 .

Agrawal SG, Lim C, Cavill I ( 2005 ) . Prospective targeted epoietin beta therapy for chemotherapy-associated anaemia achieves high response rates . BLOOD . vol. 106 , 175A - 175A .

Popat R, Oakervee HE, Curry N, Foot N, Morris C, Drake M, Agrawal S, Smith P et al. ( 2005 ) . Reduced dose PAD combination therapy (PS-341/bortezomib, adriamycin and dexamethasone) for previously untreated patients with multiple myeloma . BLOOD . vol. 106 , 717A - 718A .

Rintala T, Agrawal S, Cavenagh J, Barts DM ( 2005 ) . \Many are called, few are chosen\ . BONE MARROW TRANSPLANTATION . vol. 35 , S324 - S325 .

Petrie JA, Milne T, Ridler C, Cavenagh JD, Agrawal SG ( 2004 ) . CD123 Expression in Chronic Lymphocytic Leukaemia - Strong Correlation with ZAP70 and CD38 Expression . Blood . vol. 104 , 4406 - 4406 .

Ridler C, Smith M, Milne T, Ebrahim F, Macey M, Lister TA, Fitzgibbon J, Cavenagh JD et al. ( 2004 ) . Flow Cytometric FLT3 Expression in Acute Leukaemias Is of Diagnostic Value but Does Not Correlate with ITD / D835Y Mutation Status . Blood . vol. 104 , 3014 - 3014 .

Petrie JA, Milne T, Ebrahim F, Cavenagh JD, Agrawal SG ( 2004 ) . Incidence of ZAP70 Positivity in Fresh Samples from Unselected Patients Presenting with a B-Cell Lymphoproliferative Disorder . Blood . vol. 104 , 4399 - 4399 .

Cavenagh JD, Popat R, Curry N, Stec J, Morris TC, Drake M, Agrawal S, Smith P et al. ( 2004 ) . PAD Combination Therapy (PS-341/Bortezomib, Adriamycin and Dexamethasone) for Previously Untreated Patients with Multiple Myeloma . Blood . vol. 104 , 1478 - 1478 .

Cavenagh JD, Curry N, Stec J, Drake M, Morris TCM, Agrawal S, Esseltine D, Schenkein D et al. ( 2004 ) . PAD therapy (bortezomib, doxorubicin and dexamethasone) for untreated multiple myeloma (MM) . Journal of Clinical Oncology vol. 22 , ( 14_suppl ) 6550 - 6550 .

McCloskey D, Rintala T, Agrawal S, Murrell C, Gupta A, Hemmatapour S, Sinnott P, Cavenagh J ( 2004 ) . Improving probabilities of identifying a matched family donor: the use of 'vertical' HLA typing . BONE MARROW TRANSPLANTATION . vol. 33 , S134 - S134 .

Cavenagh JD, Curry N, Stec J, Drake M, Morris TCM, Agrawal S, Esseltine D, Schenkein D et al. ( 2004 ) . PAD therapy (bortezomib, doxorubicin and dexamethasone) for untreated multiple myeloma (MM) . JOURNAL OF CLINICAL ONCOLOGY . vol. 22 , 570S - 570S .

Feng W, Liu F, Patwari Y, Agrawal SG, Newland AC, Jia L ( 2003 ) . BH3‐domain mimetic compound BH3I‐2′ induces rapid damage to the inner mitochondrial membrane prior to the cytochrome <i>c</i> release from mitochondria . British Journal of Haematology vol. 121 , ( 2 ) 332 - 340 .

Jia L, Patwari Y, Kelsey SM, Srinivasula SM, Agrawal SG, Alnemri ES, Newland AC ( 2003 ) . Role of Smac in human leukaemic cell apoptosis and proliferation . Oncogene vol. 22 , ( 11 ) 1589 - 1599 .

Schiavon V, Elhabazi A, Agrawal S, Tawab A, Nikolova M, Boumsell L, Bensussan A ( 2002 ) . G10.3 monoclonal antibody identifies novel functional cell surface structures expressed by normal B lymphocytes and various malignant cell lines . Tissue Antigens vol. 53 , ( 1 ) 23 - 32 .

Agrawal SG, Milne TM, Marquet J, Platton SJ, Wilkes SJ, Cavenagh JD, Feng TL, Amess J et al. ( 2002 ) . CD160 expression in low grade B-cell lymphoproliferative disorders . BLOOD . vol. 100 , 384A - 384A .

Bercovici N, Massicard S, Agrawal S, Pauillac F, Duffour MT, Boccaccio C, Boyer A, Nardin A et al. ( 2001 ) . Dendritic cells generated in the presence of IL-13 and GM-CSF in a GMP large scale production process are potent tumor antigen stimulators and are well tolerated by cancer patients . European Journal of Cancer vol. 37 , S35 - S35 .

Agrawal SG, Marquet J, Plumas J, Rouard H, Delfau-Larue M-H, Gaulard P, Boumsell L, Reyes F et al. ( 2001 ) . Multiple co-stimulatory signals are required for triggering proliferation of T cells from human secondary lymphoid tissue . International Immunology vol. 13 , ( 4 ) 441 - 450 .

Bercovici N, Duffour M-T, Agrawal S, Salcedo M, Abastado J-P ( 2000 ) . New Methods for Assessing T-Cell Responses . vol. 7 , is. 6 , pp. 859 - 864 . American Society for Microbiology

Rouard H, Léon A, Klonjkowski B, Marquet J, Tennezé L, Plonquet A, Agrawal SG, Abastado J-P et al. ( 2000 ) . Adenoviral transduction of human ‘clinical grade’ immature dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacity . Journal of Immunological Methods vol. 241 , ( 1-2 ) 69 - 81 .

Jacob M-C, Agrawal S, Chaperot L, Giroux C, Gressin R, Marc’Hadour FL, Favre M, Sotto J-J et al. ( 1999 ) . Quantification of cellular adhesion molecules on malignant B cells from non-Hodgkin’s lymphoma . Leukemia vol. 13 , ( 9 ) 1428 - 1433 .

Chaperot L, Delfau-Larue M-H, Jacob M-C, Molens J-P, Roussel B, Agrawal S, Farcet J-P, Gressin R et al. ( 1999 ) . Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin’s lymphomas . Experimental Hematology vol. 27 , ( 7 ) 1185 - 1193 .

Agrawal S, Marquet J, Freeman GJ, Tawab A, Bouteiller PL, Roth P, Bolton W, Ogg G et al. ( 1999 ) . Cutting Edge: MHC Class I Triggering by a Novel Cell Surface Ligand Costimulates Proliferation of Activated Human T Cells . The Journal of Immunology vol. 162 , ( 3 ) 1223 - 1226 .

Agrawal S, Marquet J, Delfau-Larue MH, Copie-Bergman C, Jouault H, Reyes F, Bensussan A, Farcet JP ( 1998 ) . CD3 hyporesponsiveness and in vitro apoptosis are features of T cells from both malignant and nonmalignant secondary lymphoid organs . Journal of Clinical Investigation vol. 102 , ( 9 ) 1715 - 1723 .

El Marsafy S, Carosella ED, Agrawal SG, Gluckman E, Mansur IG, Elhabazi A, Boumsell L, Bensussan A ( 1996 ) . Functional role of PECAM-1/CD31 molecule expressed on human cord blood progenitors . Leukemia vol. 10 , ( 8 ) 1340 - 1346 .